2'-Deoxy-2'-fluoro-4-thiouridine>95.0%(HPLC)(qNMR)25mg

2-Amino-3-bromo-5-(trifluoromethyl)benzonitrile, 97.0%, 1g

(S)-3-(Toluene-4-sulfonyloxy)-pyrrolidine-1-carboxylic acid tert-butyl ester, 1g

5,6-Dichloropyridazin-3(2H)-one, 95.0%, 250g

7-(Trifluoromethyl)-2H-1,4-benzoxazin-3(4H)-one, 97%, 1g

1-PHENYL-3-AZABICYCLO[3.1.0]HEXANE, 95.0%, 250mg

1,8-Diazaspiro[4.5]decan-2-one hydrochloride, 95.0%, 1g

tert-Butyl (S)-2-((1R,2S)-3-(benzyloxy)-1-hydroxy-2-methyl-3-oxopropyl)pyrrolidine-1-carboxylate, 98%, 25mg

Methyl 2-(2-bromothiazol-4-yl)acetate, 97%, 1g

6-Bromo-8-chloro-2-methylimidazo[1,2-a]pyrazine, 98%, 1g

2-(4-broMo-2-chlorophenoxy)-N-(4-(N-(4,6-diMethylpyriMidin-2-yl)sulfaMoyl)phenylcarbaMothioyl)acetaMide, 95%, 50mg

SPE Cartridges CHROMAFIX® C18, 0.8 ml, Medium, 50 Piece(s)

Dimethyl Adipate>99.0%(GC)25mL